61-70 items (total 83)
Published on July 20, 2022
Synergistic Action of Two Sugars as Nutrients for Gut Bacteria Suppresses Obesity—Hopes for Developing New Prebiotics by Combining Microbiota-Accessible Carbohydrates
Office of Communications and Public Relations
Published on May 23, 2022
Discovery that Drug-Sensitive Strains Acquire Drug Resistance via Extracellular Vesicles Secreted by Treatment-Resistant Multiple Myeloma Cells—Elucidating One Mechanism by Which Drugs Lose Efficacy with Long-Term Use—
Office of Communications and Public Relations
Published on May 23, 2022
The June 2022 issue of *Jikken Igaku* (Experimental Medicine), titled "Tackling Disease from the Gut: Microbiome Drug Discovery," has been published. This special issue
Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences
Published on April 21, 2022
Phase 1 Trial Results Published for Gut Microbiota Drug (VE303) Developed by Inventor Professor Kim Im-gi
Faculty of Pharmacy/Graduate School of Pharmaceutical Sciences
Published on March 09, 2022
Discovery That Gut Bacteria Enhance Defense Against Oxidative Stress—Hopes for Drug Discovery and Food Development Utilizing Reactive Sulfur-Producing Bacteria That Suppress Oxidative Stress
Office of Communications and Public Relations
Published on February 15, 2022
Establishing Organoids for Personalized Medicine in Biliary Tract Cancer—Presenting Future Prospects through an International Multi-center Collaborative Study
Office of Communications and Public Relations
Published on November 15, 2021
Discovery that Prognosis of Immune Checkpoint Inhibitor Treatment Can Be Predicted by Combining Concomitant Medications and Neutrophil-to-Lymphocyte Ratio—Hopes for the Development of New Methods to Improve Efficacy—
Office of Communications and Public Relations
Published on October 05, 2021
Gut Microbiota-Derived Acetate Improves Hepatic Insulin Resistance and Suppresses Non-alcoholic Steatohepatitis (NASH) - Potential for Next-Generation NASH Therapies Targeting Gut Microbiota -
Office of Communications and Public Relations
Published on September 27, 2021
Marine Dietary Fiber Alginic Acid Found to Suppress Metabolic Syndrome via Gut Microbiota—Hopes for Development of Preventive Measures by Improving the Gut Environment
Office of Communications and Public Relations
Published on September 03, 2021
Development of a Novel Cyanide Antidote from Artificial Red Blood Cells: Expected to be Effective in Treating Cyanide Poisoning with its Rapid Action and Versatility
Office of Communications and Public Relations